Review Breakdown,2A peptides are active when transposed into other proteins

In the realm of molecular biology and genetic engineering, the efficient expression of multiple genes from a single transcript is a significant challenge. This is where 2A peptides and, more specifically, the T2A cleavage peptide, have emerged as invaluable tools. These self-cleaving peptides, typically 18-22 amino acids long, are derived from viral sequences and possess the remarkable ability to induce ribosomal skipping during protein translation. This unique mechanism allows for the production of distinct proteins from a single messenger RNA (mRNA) molecule, a process known as polycistronic expression.

The T2A cleavage peptide is a prominent member of the 2A peptide family, which also includes P2A, E2A, and F2A. Research has consistently highlighted the exceptional performance of the T2A sequence in achieving high cleavage efficiency. Studies have reported mean cleavage rates of 99.6% and 97.4% for T2A, placing it among the most effective 2A peptides for this purpose. This high efficiency is crucial for ensuring that each intended protein is produced in sufficient quantities and with minimal read-through or incomplete processing. The specific sequence of the T2A peptide and its interaction with the ribosome are key to this peptide bond skipping event.

The mechanism by which T2A and other 2A peptides function involves a unique ribosomal pausing and skipping event. As the ribosome translates the mRNA, it encounters the 2A peptide sequence. The C-terminal portion of the 2A peptide mimics a stop codon, causing the ribosome to pause. However, instead of terminating translation, the ribosome then "skips" the preceding peptide bond, effectively resulting in the release of the upstream protein while translation continues for the downstream protein(s). This results in the production of equimolar amounts of separate proteins, each with a few additional amino acids at their C-terminus (from the 2A peptide sequence) and, in the case of T2A, often a proline residue at the N-terminus of the downstream protein. The T2A cleavage process is remarkably efficient, and efforts have been made to further optimize the 2A peptide sequence, including exploring variants like T2A20, which has demonstrated high cleavage efficiency.

The utility of the T2A cleavage peptide extends across various applications. In mammalian cell lines, 2A self-cleaving peptides are frequently used to co-express multiple proteins from a single vector. This simplifies experimental design and can lead to more synchronized protein expression. For instance, researchers might use a T2A self-cleaving peptide to link a reporter protein with a gene of interest, allowing for easy monitoring of gene delivery and expression. Furthermore, the T2A peptide linker has been employed in the development of bicistronic vectors and multigene expression systems (MGES). The ability to achieve high cleavage efficiency is paramount in these systems to ensure the successful and faithful expression of multiple proteins.

While P2A is also known for its high cleavage efficiency, research comparing T2A vs P2A often shows them performing comparably, with T2A being a highly reliable choice. The T2A gene itself is a small, well-defined sequence that can be readily incorporated into expression constructs. The structure of the T2A peptide is intrinsically linked to its function, with specific amino acid residues playing critical roles in the ribosomal skipping mechanism. Understanding the nuances of T2A sequence function is key to maximizing its effectiveness in experimental settings.

Beyond mammalian systems, the application of 2A peptides is expanding. Research is exploring their use in plant biotechnology and even in bacterial systems, although their efficiency in prokaryotes can vary. The fundamental principle remains the same: utilizing these self-cleaving 2A peptides to enable the coordinated expression of multiple genes. The peptide itself acts as an autonomous element, active when transposed into other proteins, mediating recoding in eukaryotic ribosomes. This versatility makes the T2A cleavage peptide a powerful tool for researchers aiming to engineer complex biological systems, develop novel therapeutics, and advance our understanding of gene regulation. The ongoing research into 2A peptide mechanism and variations continues to refine and expand the applications of these remarkable molecular tools.